# Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy

> **NCT05610215** · NA · RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 66 (estimated)

## Conditions studied

- Atrial Fibrillation
- Cardiomyopathy, Hypertrophic
- Radiofrequency Ablation

## Interventions

- **PROCEDURE:** hybrid ablation
- **PROCEDURE:** catheter ablation

## Key facts

- **NCT ID:** NCT05610215
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-11
- **Primary completion:** 2025-12
- **Final completion:** 2026-12
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2024-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05610215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05610215, "Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05610215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*